Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Shattuck Labs
STTK
$687M
| $467K | ﹤0.01% |
120,959
+100,078
| +479% | +$814K |
|
3227
Evolution Petroleum
EPM
$131M
| $467K | ﹤0.01% |
88,524
+5,076
| +6% | +$28.5K |
|
|
SPYM
3228
State Street SPDR Portfolio S&P 500 ETF
SPYM
$160B
| $466K | ﹤0.01% |
+7,287
| New | +$449K |
|
3229
The Joint Corp
JYNT
$119M
| $466K | ﹤0.01% |
33,150
-6,848
| -17% | -$97.6K |
|
3230
ESS Tech
GWH
$22.3M
| $466K | ﹤0.01% |
37,971
-13,144
| -26% | -$148K |
|
3231
Viant Technology
DSP
$229M
| $466K | ﹤0.01% |
47,165
+3,563
| +8% | +$33.2K |
|
3232
BCB Bancorp
BCBP
$177M
| $463K | ﹤0.01% |
43,585
+2,832
| +7% | +$28.3K |
|
3233
Purple Innovation
PRPL
$31.6M
| $459K | ﹤0.01% |
17,663
+85
| +0.5% | +$2.99K |
|
3234
Virginia National Bankshares
VABK
$249M
| $458K | ﹤0.01% |
13,968
+904
| +7% | +$26.3K |
|
3235
Virco
VIRC
$94.4M
| $457K | ﹤0.01% |
+32,818
| New | +$407K |
|
3236
Sera Prognostics
SERA
$82.2M
| $457K | ﹤0.01% |
77,113
+65,113
| +543% | +$582K |
|
3237
Hooker Furnishings Corp
HOFT
$150M
| $455K | ﹤0.01% |
31,422
+2,026
| +7% | +$35.5K |
|
3238
Heritage Insurance Holdings
HRTG
$907M
| $454K | ﹤0.01% |
64,148
+54,023
| +534% | +$477K |
|
3239
Commercial Vehicle Group
CVGI
$147M
| $454K | ﹤0.01% |
92,669
+5,818
| +7% | +$33K |
|
3240
Aldeyra Therapeutics
ALDX
$96.5M
| $453K | ﹤0.01% |
136,733
+11,208
| +9% | +$43.9K |
|
3241
Redwire
RDW
$2.02B
| $452K | ﹤0.01% |
63,108
+34,880
| +124% | +$168K |
|
3242
Achieve Life Sciences
ACHV
$647M
| $451K | ﹤0.01% |
+95,886
| New | +$462K |
|
3243
Trevi Therapeutics
TRVI
$2.61B
| $450K | ﹤0.01% |
150,918
+43,211
| +40% | +$120K |
|
3244
J. Jill
JILL
$265M
| $448K | ﹤0.01% |
12,809
+847
| +7% | +$26K |
|
3245
Bankwell Financial Group
BWFG
$540M
| $447K | ﹤0.01% |
17,636
+1,680
| +11% | +$40.9K |
|
3246
Chemung Financial Corp
CHMG
$391M
| $447K | ﹤0.01% |
9,321
| – | – |
|
3247
Southern California Bancorp
BCAL
$679M
| $447K | ﹤0.01% |
+33,164
| New | +$461K |
|
3248
CVRx
CVRX
$143M
| $445K | ﹤0.01% |
37,154
+5,921
| +19% | +$68.2K |
|
|
SEVN
3249
Seven Hills Realty Trust
SEVN
$171M
| $445K | ﹤0.01% |
+35,112
| New | +$442K |
|
|
CALB
3250
DELISTED
California BanCorp Common Stock
CALB
| $445K | ﹤0.01% |
+20,679
| New | +$446K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.